An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity.
Yao Y, Wu M, Wang Y, Liao Z, Yang Y, Liu Y, Shi J, Wu W, Wei X, Xu J, Guo Y, Dong X, Che J, Wang J, Gu Z.
Yao Y, et al. Among authors: xu j.
Adv Mater. 2024 Nov 20:e2411454. doi: 10.1002/adma.202411454. Online ahead of print.
Adv Mater. 2024.
PMID: 39568237